Life Science Company News

Reset
Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Viatris Inc.

AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  Amgen Inc.

Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

Sanofi Canada invests $180M CAD to build and update infrastructure to minimize environmental footprint at its Toronto Campus by 50%

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024

WELL Health to Expand its Canadian Clinic Network with Acquisition from Shoppers Drug Mart Inc. of Medical Clinics operating as "The Health Clinic by Shoppers™"

Read more ››
By: PR Newswire Association LLC. - 16 Apr 2024
Related companies:  WELL Health Technologies Corp.

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Genmab A/S

Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Cullinan Therapeutics, Inc.

Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Ocular Therapeutix, Inc.

Imugene and Kincell Bio Announce Strategic Manufacturing and Process Development Partnership

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Kincell Bio

Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Foghorn Therapeutics, Inc.

Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Cullinan Therapeutics, Inc.

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  AxoGen, Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  EyePoint Pharmaceuticals, Inc.

Treace Announces First Annual National Bunion Day

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Treace Medical Concepts, Inc.

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Voyager Therapeutics, Inc.

Vistin Pharma ASA: Invitation to Q1 2024 conference call

Read more ››
By: GlobeNewswire - 16 Apr 2024

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Intra-Cellular Therapies, Inc.

Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Clearside Biomedical, Inc.

St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Arch Biopartners, Inc.

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates

Read more ››
By: GlobeNewswire - 16 Apr 2024
Related companies:  Eloxx Pharmaceuticals, Inc.
Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25

Enhance your business development with Biotechgate
Try for free »